Combined oral cyclophosphamide and bevacizumab in heavily pre-treated ovarian cancer

被引：0
|
作者：
José Miguel Jurado García
Alfonso Sánchez
Bella Pajares
Elisabeth Pérez
Lorenzo Alonso
Emilio Alba
机构：
[1] Hospital Universitario Virgen de la Victoria,Medical Oncology Service
来源：
Clinical and Translational Oncology | 2008年 / 10卷
关键词：
Ovarian cancer; Platinum resistant; Bevacizumab; Metronomic cyclophosphamide;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Phase II study of the combination carboplatin plus celecoxib in heavily pre-treated recurrent ovarian cancer patients
    Legge, Francesco
    Paglia, Amelia
    D'Asta, Marco
    Fuoco, Gilda
    Scambia, Giovanni
    Ferrandina, Gabriella
    BMC CANCER, 2011, 11
  • [32] BEVACIZUMAB PLUS METRONOMIC CYCLOPHOSPHAMIDE FOR HEAVILY PRETREATED OVARIAN CANCER: A SINGLE INSTITUTION EXPERIENCE
    Ghanem, I.
    Mendiola, C.
    Diaz, A.
    Velasco, G.
    Manso, L.
    Ciruelos, E.
    Manneh, R. A.
    Hoyos, S.
    Pascual, T.
    Cortes-Funes, H.
    ANNALS OF ONCOLOGY, 2012, 23 : 325 - 325
  • [33] Salvage therapy with combined cyclophosphamide (C), fludarabine (F), alemtuzumab (A), and rituximab (R) (CFAR) for heavily pre-treated patients with CLL.
    Wierda, WG
    OBrien, S
    Ferrajoli, A
    Faderl, S
    Koller, C
    Giles, F
    Cortes, J
    Thomas, D
    Ravandi, F
    Garcia-Manero, G
    Andreeff, M
    Lerner, S
    Kantarjian, H
    Keating, M
    BLOOD, 2005, 106 (11) : 213A - 213A
  • [34] Bevacizumab and oral metronomic cyclophosphamide in platinum-resistant ovarian cancer
    Pujade-Lauraine, Eric
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2013, 24 (03) : 209 - 211
  • [35] Polymorphisms and Clinical Outcome in Recurrent Ovarian Cancer Treated with Cyclophosphamide and Bevacizumab
    Schultheis, Anne M.
    Lurje, Georg
    Rhodes, Katrin E.
    Zhang, Wu
    Yang, Dongyun
    Garcia, Agustin A.
    Morgan, Robert
    Gandara, David
    Scudder, Sidney
    Oza, Amit
    Hirte, Hal
    Fleming, Gini
    Roman, Lynda
    Lenz, Heinz-Josef
    CLINICAL CANCER RESEARCH, 2008, 14 (22) : 7554 - 7563
  • [36] TREATMENT WITH ERIBULIN (HALAVEN) IN HEAVILY PRE-TREATED PATIENTS WITH METASTATIC BREAST CANCER
    Lynge, M.
    Liposits, G. I.
    Linnet, S.
    Langkjer, S. T.
    BREAST, 2013, 22 : S43 - S43
  • [37] Treatment with eribulin (halaven) in heavily pre-treated patients with metastatic breast cancer
    Rasmussen, Maja Lynge
    Liposits, Gabor
    Yogendram, Subethini
    Jensen, Anders Bonde
    Linnet, Soren
    Langkjer, Sven Tyge
    ACTA ONCOLOGICA, 2014, 53 (09) : 1275 - +
  • [38] Weekly topotecan as a salvage therapy in heavily pre-treated patients with recurrent platinum-resistant epithelial ovarian cancer
    Marinaccio, M.
    De Marino, E.
    Mele, E.
    Catacchio, R.
    Meo, D.
    Iezzoni, C.
    Conversano, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [39] Treosulfan for advanced breast cancer in a heavily pre-treated patient - a case report
    Terjung, A.
    Altgassen, C.
    Friedrich, M.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2017, 38 (01) : 115 - 117
  • [40] Phase I and pharmacological study of single paclitaxel administered weekly for heavily pre-treated patients with epithelial ovarian cancer
    Takano, M
    Kikuchi, Y
    Kita, T
    Suzuki, M
    Ohwada, M
    Yamamoto, T
    Yamamoto, K
    Inoue, H
    Shimizu, K
    ANTICANCER RESEARCH, 2002, 22 (03) : 1833 - 1838
12345